$Zai Lab Ltd(ZLAB)$ 's Supplemental New Drug Application for Ripretinib has been officially accepted by NMPA, and the progress bar for innovative drugs has been filled up again! This wave is really worth watching, and it is one step closer to the official launch. The fundamentals are about to be realized.
Winning Trades
Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments